Company Info
Phone(858) 283-3926
Year Established
2011
Ticker
ADAG
Exchange
NASDAQ
Contacts
Peter Luo, Ph.D.Chair, CEO & President, R&D
Alexander Goergen
Head of Business Development
JC Xu, M.D., Ph.D.
CSO
Qinghai Zhao, Ph.D.
Chief Manufacturing Officer
Man Kin (Raymond) Tam, M.B.A
CFO
Felix (Fangyong) Du, Ph.D.
CTO
Company Description
Adagene is a publicly traded, global, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.